Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

To evaluate the response rate and toxicity of the combination of irinotecan (CPT-11) and cisplatin in a neoadjuvant setting, a phase II study was conducted regarding the regimen of this combination in patients with locally advanced cervical cancer. Eligibility included patients with previously untre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, T, Nishida, T, Kumagai, S, Nishio, S, Fujiyoshi, K, Okura, N, Yakushiji, M, Hiura, M, Umesaki, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374351/
https://www.ncbi.nlm.nih.gov/pubmed/10487618
http://dx.doi.org/10.1038/sj.bjc.6690656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374351/
https://www.ncbi.nlm.nih.gov/pubmed/10487618
http://dx.doi.org/10.1038/sj.bjc.6690656

Ejemplares similares